Attitudes towards Vaccines, Intent to Vaccinate and the Relationship with COVID-19 Vaccination Rates in Individuals with Schizophrenia.
COVID-19
attitudes
schizophrenia
vaccination
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
31 Jul 2022
31 Jul 2022
Historique:
received:
09
06
2022
revised:
25
07
2022
accepted:
28
07
2022
entrez:
26
8
2022
pubmed:
27
8
2022
medline:
27
8
2022
Statut:
epublish
Résumé
Schizophrenia patients are at high risk of developing severe COVID-19 outcomes but recent evidence suggests that they are under-vaccinated. This study explored the role of potential attitudinal barriers by comparing schizophrenia patients with participants from the general population regarding COVID-19 vaccination rates, general attitudes towards vaccines, and willingness to take a COVID-19 vaccine. We conducted a cross-sectional study between April 2021 and October 2021. A total of 100 people with schizophrenia and 72 nonclinical controls were recruited. In our study, individuals with schizophrenia were under-vaccinated, despite similar general attitudes towards vaccination and higher willingness to be vaccinated against COVID-19 compared to nonclinical participants. In patients, negative attitudes toward vaccines were related to higher levels of negative psychotic symptoms and higher levels of paranoid ideation. As a whole, participants with more negative attitudes towards vaccines were less likely to be vaccinated against COVID-19 and had lower levels of trust in institutions. Vaccine hesitancy does not appear to be a major barrier for COVID-19 vaccine uptake amongst people with schizophrenia. This study suggests that disparities in COVID-19 vaccination rates in schizophrenia do not seem related to attitudinal but rather structural barriers.
Identifiants
pubmed: 36016116
pii: vaccines10081228
doi: 10.3390/vaccines10081228
pmc: PMC9414756
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Agence Nationale de la Recherche
ID : SCHIZOVAC; ANR-21-COVR-0017
Références
J Pers Med. 2022 Jan 14;12(1):
pubmed: 35055426
Vaccine. 2021 Apr 8;39(15):2024-2034
pubmed: 33722411
Schizophr Res. 2021 May;231:49-50
pubmed: 33752107
Australas Psychiatry. 2019 Apr;27(2):171-178
pubmed: 30501496
Lancet Psychiatry. 2021 May;8(5):444-450
pubmed: 33548184
Nat Commun. 2021 Jan 4;12(1):29
pubmed: 33397962
Eur Psychiatry. 2014 Sep;29(7):449-55
pubmed: 24630742
World Psychiatry. 2021 Feb;20(1):54-55
pubmed: 33131217
Acta Psychiatr Scand. 2022 Aug;146(2):168-178
pubmed: 35322409
Int J Psychiatry Med. 2013;46(1):1-13
pubmed: 24547606
Psychol Med. 2021 Dec 17;:1-3
pubmed: 34915962
World Psychiatry. 2022 Feb;21(1):153-154
pubmed: 35015350
BJPsych Open. 2021 Aug 11;7(5):e146
pubmed: 34422295
Thorax. 2013 Feb;68(2):171-6
pubmed: 23242947
JAMA Psychiatry. 2021 Jun 1;78(6):589-590
pubmed: 33320243
BMJ Open. 2021 Aug 2;11(8):e048025
pubmed: 34341047
Schizophr Bull. 2021 Aug 21;47(5):1211-1217
pubmed: 33604657
Pharm Pract (Granada). 2021 Jan-Mar;19(1):2317
pubmed: 33828623
J Am Psychiatr Nurses Assoc. 2020 Mar/Apr;26(2):172-180
pubmed: 30866701
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
Glob Health J. 2021 Mar;5(1):51-55
pubmed: 33585053
Vaccine. 2018 Nov 19;36(48):7262-7269
pubmed: 30340886
Lancet. 2020 Sep 26;396(10255):898-908
pubmed: 32919524
Schizophr Bull. 2021 Apr 29;47(3):624-634
pubmed: 33089862
Int J Environ Res Public Health. 2021 Sep 04;18(17):
pubmed: 34501932
BMJ Open. 2021 Oct 28;11(10):e055085
pubmed: 34711602
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
J Psychiatr Res. 2021 Nov;143:16-20
pubmed: 34438198
World Psychiatry. 2021 Feb;20(1):124-130
pubmed: 33026219
Br J Psychiatry. 2021 Jun;218(6):344-351
pubmed: 33407954
Psychol Med. 2022 Jan;52(2):251-263
pubmed: 32436485
Int J Environ Res Public Health. 2021 Sep 20;18(18):
pubmed: 34574827
Acta Neuropsychiatr. 2021 Oct;33(5):273-276
pubmed: 33998428
J Pers Soc Psychol. 1984 Dec;47(6):1191-205
pubmed: 6527214
Lancet Psychiatry. 2021 Oct;8(10):901-908
pubmed: 34364406
Ann Behav Med. 2017 Oct;51(5):652-660
pubmed: 28255934
Lancet Psychiatry. 2021 Oct;8(10):860-861
pubmed: 34416185
Eur Arch Psychiatry Clin Neurosci. 2022 Apr 30;:
pubmed: 35501605
Lancet Reg Health Eur. 2021 Feb;1:100012
pubmed: 33954296
BMC Public Health. 2021 Apr 28;21(1):818
pubmed: 33910558